• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大肝切除术中的门静脉栓塞术

Portal vein embolization in extended liver resection.

作者信息

Narula Nisha, Aloia Thomas A

机构信息

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Herman Pressler Drive, Unit 1484, Houston, TX, 77030, USA.

出版信息

Langenbecks Arch Surg. 2017 Aug;402(5):727-735. doi: 10.1007/s00423-017-1591-8. Epub 2017 May 31.

DOI:10.1007/s00423-017-1591-8
PMID:28567528
Abstract

BACKGROUND

Liver resection of benign, primary, and metastatic tumors is challenging and places patients at risk of postoperative liver insufficiency. This risk is largely dependent on the volume and function of the future liver remnant (FLR). It is, therefore, critical that hepatobiliary surgeons are well versed in the measurement of liver volume and function, as well as various techniques for preoperative liver volume augmentation.

PURPOSE

This comprehensive review of portal vein embolization (PVE) begins with an overview of FLR measurement and progresses to patient factors to consider when choosing PVE and assessment of hypertrophy. PVE techniques and complications are subsequently discussed.

CONCLUSIONS

The absolute volume of FLR required to avoid postoperative liver insufficiency is dependent on the patient, disease, and anatomic factors. Rapid expansion of the FLR can be achieved with PVE of contralateral liver segments. Although multiple metrics have been used to correlate hypertrophy with postoperative outcomes after PVE, the kinetic growth rate (KGR) is the most reliable predictor of freedom from postoperative liver insufficiency. PVE is now considered a safe and effective procedure when performed at high-volume hepatobiliary centers. It is an effective tool that, by lowering the risk of liver failure, increases the number of patients who can undergo potential curative hepatectomy.

摘要

背景

良性、原发性和转移性肿瘤的肝切除术具有挑战性,会使患者面临术后肝功能不全的风险。这种风险很大程度上取决于未来肝残余量(FLR)的体积和功能。因此,肝胆外科医生精通肝脏体积和功能的测量以及术前肝脏体积增大的各种技术至关重要。

目的

本对门静脉栓塞术(PVE)的全面综述首先概述FLR测量,然后探讨选择PVE时要考虑的患者因素以及肥大评估。随后讨论PVE技术和并发症。

结论

避免术后肝功能不全所需的FLR绝对体积取决于患者、疾病和解剖因素。对侧肝段的PVE可实现FLR的快速增大。尽管已使用多种指标将肥大与PVE后的术后结果相关联,但动力学生长率(KGR)是预测无术后肝功能不全最可靠的指标。在大容量肝胆中心进行PVE时,现在认为它是一种安全有效的手术。它是一种有效的工具,通过降低肝衰竭风险,增加了能够接受潜在根治性肝切除术的患者数量。

相似文献

1
Portal vein embolization in extended liver resection.扩大肝切除术中的门静脉栓塞术
Langenbecks Arch Surg. 2017 Aug;402(5):727-735. doi: 10.1007/s00423-017-1591-8. Epub 2017 May 31.
2
Preoperative Assessment and Optimization of the Future Liver Remnant.未来肝残余体积的术前评估与优化
Surg Clin North Am. 2016 Apr;96(2):197-205. doi: 10.1016/j.suc.2015.11.001. Epub 2016 Feb 16.
3
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.经肝同侧右门静脉栓塞扩展至IV段:使用球形颗粒和线圈改善肥大及切除效果
J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):215-25. doi: 10.1097/01.RVI.0000147067.79223.85.
4
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.HYPER-LIV01 试验方案:一项多中心、前瞻性、随机对照研究,比较同时门静脉和肝静脉栓塞与门静脉栓塞在结直肠肝转移行大范围肝切除前对未来肝残留量的肝体积增大的效果。
BMC Cancer. 2020 Jun 19;20(1):574. doi: 10.1186/s12885-020-07065-z.
5
Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients.用聚乙烯醇颗粒和弹簧圈进行门静脉栓塞以准备行肝胆恶性肿瘤的大肝切除术:安全性和有效性——26例患者的研究
Radiology. 2003 Apr;227(1):251-60. doi: 10.1148/radiol.2271012010. Epub 2003 Feb 28.
6
Portal vein embolization before right hepatectomy: prospective clinical trial.右肝切除术前门静脉栓塞:前瞻性临床试验
Ann Surg. 2003 Feb;237(2):208-17. doi: 10.1097/01.SLA.0000048447.16651.7B.
7
Radiological Simultaneous Portohepatic Vein Embolization (RASPE) Before Major Hepatectomy: A Better Way to Optimize Liver Hypertrophy Compared to Portal Vein Embolization.放射学同步门腔静脉栓塞术(RASPE)在肝切除术之前:与门静脉栓塞术相比,优化肝脏肥大的更好方法。
Ann Surg. 2020 Aug;272(2):199-205. doi: 10.1097/SLA.0000000000003905.
8
Portal Vein Embolization Utilizing N-Butyl Cyanoacrylate for Contralateral Lobe Hypertrophy Prior to Liver Resection: A Systematic Review and Meta-Analysis.利用氰基丙烯酸正丁酯进行门静脉栓塞以促进肝切除术前对侧肝叶肥大:一项系统评价和荟萃分析
Cardiovasc Intervent Radiol. 2018 Sep;41(9):1302-1312. doi: 10.1007/s00270-018-1964-6. Epub 2018 Apr 23.
9
Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization.门静脉栓塞后影响肝左外叶肥大的因素。
Langenbecks Arch Surg. 2015 Feb;400(2):237-46. doi: 10.1007/s00423-014-1266-7. Epub 2015 Jan 6.
10
Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS.门静脉栓塞后经皮微波消融肝内分割术(PISA)促进未来肝残余体积增大的可行性:放射学1期ALPPS。
Cardiovasc Intervent Radiol. 2018 May;41(5):789-798. doi: 10.1007/s00270-018-1882-7. Epub 2018 Jan 22.

引用本文的文献

1
The Cross-Sectional Area Ratio of Right-to-Left Portal Vein Predicts the Effect of Preoperative Right Portal Vein Embolization.右向左门静脉截面积比值预测术前右门静脉栓塞的效果。
Medicina (Kaunas). 2024 Jul 9;60(7):1114. doi: 10.3390/medicina60071114.
2
Assessment of Segmentary Hypertrophy of Future Remnant Liver after Liver Venous Deprivation: A Single-Center Study.肝静脉阻断后未来残余肝节段性肥大的评估:一项单中心研究
Cancers (Basel). 2024 May 23;16(11):1982. doi: 10.3390/cancers16111982.
3
Decreased mebrofenin uptake in patients with non-colorectal liver tumors requiring liver volume augmentation-a single-center analysis.

本文引用的文献

1
Portal Vein Embolization: Impact of Chemotherapy and Genetic Mutations.门静脉栓塞:化疗和基因突变的影响
J Clin Med. 2017 Mar 1;6(3):26. doi: 10.3390/jcm6030026.
2
Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.肝细胞癌、胆管癌和结直肠癌肝转移患者术前门静脉栓塞的疗效:基于319例单中心经验的比较研究
Ann Surg Oncol. 2017 Jun;24(6):1557-1568. doi: 10.1245/s10434-017-5800-z. Epub 2017 Feb 10.
3
Comparison of MRI- and CT-based semiautomated liver segmentation: a validation study.
需要增加肝脏体积的非结直肠癌肝肿瘤患者中米洛芬摄取减少——一项单中心分析
Langenbecks Arch Surg. 2024 Mar 11;409(1):92. doi: 10.1007/s00423-024-03280-5.
4
Preoperative predictors for non-resectability in perihilar cholangiocarcinoma.肝门周围胆管癌不可切除的术前预测因素。
World J Surg Oncol. 2024 Feb 7;22(1):48. doi: 10.1186/s12957-024-03329-1.
5
Portal vein embolization with N-butyl-cyanoacrylate improves liver hypertrophy compared to microparticles - A Swedish multicenter cohort study.与微粒相比,使用氰基丙烯酸正丁酯进行门静脉栓塞可改善肝脏肥大——一项瑞典多中心队列研究。
Heliyon. 2023 Oct 22;9(11):e21210. doi: 10.1016/j.heliyon.2023.e21210. eCollection 2023 Nov.
6
Non-target lung embolization during portal vein embolization due to an unrecognized portosystemic venous fistula: A case report.因未识别的门体静脉瘘导致门静脉栓塞期间的非靶肺栓塞:一例报告。
World J Clin Cases. 2023 May 26;11(15):3625-3630. doi: 10.12998/wjcc.v11.i15.3625.
7
Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma.术后早期骨骼肌量减少预测肝门周围胆管癌切除术后复发和不良生存。
BMC Cancer. 2022 Dec 28;22(1):1358. doi: 10.1186/s12885-022-10453-2.
8
Application of hepatic lobe hyperplasia techniques in the treatment of advanced hepatic alveolar echinococcosis: a single-centre experience.肝叶增生技术在治疗晚期肝泡型包虫病中的应用:单中心经验。
BMC Surg. 2022 Dec 6;22(1):415. doi: 10.1186/s12893-022-01864-w.
9
Laparoscopic right hemihepatectomy following a novel optimized portal vein embolization: a video case report.腹腔镜下右半肝切除术后新型优化门静脉栓塞术:病例视频报告。
BMC Gastroenterol. 2022 Jun 3;22(1):284. doi: 10.1186/s12876-022-02321-x.
10
Neoadjuvant treatment strategies for hepatocellular carcinoma.肝细胞癌的新辅助治疗策略
World J Gastrointest Surg. 2021 Dec 27;13(12):1550-1566. doi: 10.4240/wjgs.v13.i12.1550.
基于 MRI 和 CT 的半自动肝脏分割的比较:一项验证研究。
Abdom Radiol (NY). 2017 Feb;42(2):478-489. doi: 10.1007/s00261-016-0912-7.
4
Preoperative Left Portal Vein Embolization for Left Liver Resection in High-Risk Hepatobiliary Malignancy Patients.高危肝胆恶性肿瘤患者左肝切除术前的门静脉左支栓塞术
World J Surg. 2016 Nov;40(11):2758-2765. doi: 10.1007/s00268-016-3618-7.
5
Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique.肝切除术前行肝门静脉和肝静脉同期栓塞:肝静脉阻断技术。
Eur Radiol. 2016 Dec;26(12):4259-4267. doi: 10.1007/s00330-016-4291-9. Epub 2016 Apr 18.
6
Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes.肝癌术前门静脉栓塞:适应证、技术及疗效
Quant Imaging Med Surg. 2015 Oct;5(5):730-9. doi: 10.3978/j.issn.2223-4292.2015.10.04.
7
Preoperative Sequential Portal and Hepatic Vein Embolization in Patients with Hepatobiliary Malignancy.肝胆恶性肿瘤患者术前序贯门静脉和肝静脉栓塞术
World J Surg. 2015 Dec;39(12):2990-8. doi: 10.1007/s00268-015-3194-2.
8
Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma.术前序贯经导管动脉化疗栓塞和门静脉栓塞对孤立性肝细胞癌患者右半肝切除术的预后影响
Korean J Hepatobiliary Pancreat Surg. 2015 May;19(2):59-65. doi: 10.14701/kjhbps.2015.19.2.59. Epub 2015 May 31.
9
Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases.门静脉栓塞术及其对结直肠癌肝转移瘤进展的影响。
Br J Surg. 2015 Sep;102(10):1240-9. doi: 10.1002/bjs.9872. Epub 2015 Jun 24.
10
Preoperative estimation of future remnant liver function following portal vein embolization using relative enhancement on gadoxetic acid disodium-enhanced magnetic resonance imaging.使用钆塞酸二钠增强磁共振成像上的相对强化对门静脉栓塞术后未来残余肝功能进行术前评估。
Korean J Radiol. 2015 May-Jun;16(3):523-30. doi: 10.3348/kjr.2015.16.3.523. Epub 2015 May 13.